Voclosporin: all 26 studies that test it
Page 1 of 1. Open to participants first (3), then studies with results posted, then the rest; newest registration first within each.
- Assessing Residual Inflammation and Macrophage Presence in Lupus Nephritis After 3 Months of Intensified Treatment With Prednisolone, Mycofenolate Mofetil and Voclosporin as Compared to Mycofenolate Mofetil and PrednisoloneRecruitingNCT07760480Phase 4
- PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus NephritisRecruitingNCT07611214Phase 4
- Safety and Efficacy of Combination Belimumab and Voclosporin in the Treatment of Proliferative Forms of Lupus Glomerulopathy: Synergy TrialRecruitingNCT07225387Phase 4
- Examining Distinct Immunophenotypes to Validate and Enhance Rational Treatment in Systemic LupusTerminatedNCT05306873Phase 2Results posted
- Dose Ranging Study to Assess the Efficacy and Safety of Voclosporin Ophthalmic Solution in Subjects With Dry Eye SyndromeCompletedNCT04147650Phase 2/3Results posted
- Dose-Exploration Evaluating the Efficacy and Safety of Voclosporin in Subjects With Focal Segmental GlomerulosclerosisTerminatedNCT03598036Phase 2Results posted
- Aurinia Renal Assessments 2: Aurinia Renal Response in Lupus With VoclosporinCompletedNCT03597464Phase 3Results posted
- Ocular Tolerability of Voclosporin Ophthalmic Solution Versus Restasis® in Subjects With Dry Eye DiseaseCompletedNCT03597139Phase 2Results posted
- Aurinia Renal Response in Active Lupus With VoclosporinCompletedNCT03021499Phase 3Results posted
- Aurinia Early Urinary Protein Reduction Predicts ResponseCompletedNCT02949973Phase 2Results posted
- AURA-LV: Aurinia Urinary Protein Reduction Active - Lupus With Voclosporin (AURA-LV)CompletedNCT02141672Phase 2Results posted
- Study of ISA247 (Voclosporin) in De Novo Renal TransplantationCompletedNCT00270634Phase 2Results posted
- Randomized Placebo-controlled Study of ISA247 in Plaque PsoriasisCompletedNCT00244842Phase 3Results posted
- Long-Term Voclosporin Treatment in Adolescent and Pediatric Subjects With Lupus NephritisTerminatedNCT05962788Phase 3
- Drug-Drug Interaction Study to Investigate Effects of Voclosporin on Pharmacokinetics of SimvastatinCompletedNCT05306379Phase 1
- Voclosporin in Adolescent and Pediatric Subjects With Lupus NephritisTerminatedNCT05288855Phase 3
- Anti-Viral Effects of Voclosporin in COVID-19 Positive Kidney Transplant RecipientsCompletedNCT04701528Phase 2
- Voclosporin in Healthy Japanese VolunteersCompletedNCT02949999Phase 1
- Safety and Efficacy Study of Voclosporin and Tacrolimus in TransplantationWithdrawnNCT01586845Phase 3
- Efficacy and Safety of Voclosporin to Treat Active Noninfectious UveitisCompletedNCT01243983Phase 3
- A Dose-Escalation Study to Assess the Safety and Tolerability of LX214 Ophthalmic Solution in Healthy Volunteers, Followed by an Open-Label Evaluation of LX214 in Patients With Keratoconjunctivitis Sicca (KCS)CompletedNCT00851734Phase 1
- Randomized, Placebo and Ciclosporin Controlled Study of ISA247 in Plaque Psoriasis PatientsCompletedNCT00408187Phase 3
- A Multi-center Study to Assess the Efficacy and Safety of LX211 in Active Non-infectious Anterior UveitisCompletedNCT00404885Phase 3
- A Study of LX211 in Clinically Quiescent Non-infectious Intermediate, Anterior and Intermediate, Posterior or Pan-UveitisCompletedNCT00404742Phase 3
- A Study of LX211 in Active Sight Threatening, Non-infectious Intermediate-, Anterior and Intermediate-, Posterior-, or Pan-UveitisCompletedNCT00404612Phase 3
- A 36-Week Extension to Protocol ISA04-03CompletedNCT00258713Phase 3